Andreas Prokesch
Overview
Explore the profile of Andreas Prokesch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1016
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abdellatif M, Vasques-Novoa F, Trummer-Herbst V, Durand S, Koser F, Islam M, et al.
Eur Heart J
. 2025 Feb;
PMID: 39995248
No abstract available.
2.
Reinisch I, Enzenhofer S, Prokesch A
Bioessays
. 2025 Jan;
e202400203.
PMID: 39828607
Adipose tissue (AT) inflammation, a hallmark of the metabolic syndrome, is triggered by overburdened adipocytes sending out immune cell recruitment signals during obesity development. An AT immune landscape persistent throughout...
3.
Michenthaler H, Duszka K, Reinisch I, Galhuber M, Moyschewitz E, Stryeck S, et al.
BMC Biol
. 2024 Nov;
22(1):268.
PMID: 39567986
Background: Dietary restriction (DR) has multiple beneficial effects on health and longevity and can also improve the efficacy of certain therapies. Diets used to instigate DR are diverse and the...
4.
Lenihan-Geels G, Garcia Carrizo F, Leer M, Gohlke S, Oster M, Pohle-Kronawitter S, et al.
J Cachexia Sarcopenia Muscle
. 2024 Jul;
15(5):1772-1784.
PMID: 39010299
Background: The ability of skeletal muscle to respond adequately to changes in nutrient availability, known as metabolic flexibility, is essential for the maintenance of metabolic health and loss of flexibility...
5.
Xu R, Vujic N, Bianco V, Reinisch I, Kratky D, Krstic J, et al.
Trends Endocrinol Metab
. 2024 May;
35(11):981-995.
PMID: 38705759
Lipid-associated macrophages (LAMs) are phagocytic cells with lipid-handling capacity identified in various metabolic derangements. During disease development, they locate to atherosclerotic plaques, adipose tissue (AT) of individuals with obesity, liver...
6.
Huber K, Giralt A, Dreos R, Michenthaler H, Geller S, Barquissau V, et al.
Biochim Biophys Acta Mol Cell Res
. 2024 Apr;
1871(5):119721.
PMID: 38580088
Metabolic reprogramming is considered as a hallmark of cancer and is clinically exploited as a novel target for therapy. The E2F transcription factor-1 (E2F1) regulates various cellular processes, including proliferative...
7.
Reinisch I, Michenthaler H, Sulaj A, Moyschewitz E, Krstic J, Galhuber M, et al.
Nat Commun
. 2024 Feb;
15(1):1391.
PMID: 38360943
In obesity, sustained adipose tissue (AT) inflammation constitutes a cellular memory that limits the effectiveness of weight loss interventions. Yet, the impact of fasting regimens on the regulation of AT...
8.
Usluer S, Galhuber M, Khanna Y, Bourgeois B, Spreitzer E, Michenthaler H, et al.
Biochim Biophys Acta Mol Cell Res
. 2023 Dec;
1871(2):119654.
PMID: 38123020
The genome is frequently targeted by genotoxic agents, resulting in the formation of DNA scars. However, cells employ diverse repair mechanisms to restore DNA integrity. Among these processes, the Mre11-Rad50-Nbs1...
9.
Krstic J, Schindlmaier K, Prokesch A
Int Rev Cell Mol Biol
. 2022 Oct;
373:159-197.
PMID: 36283766
Therapeutically interfering with metabolic pathways has great merit to curtail tumor growth because the demand for copious amounts of energy for growth-supporting biomass production is common to all cancer entities....
10.
Klymiuk I, Bilgilier C, Mahnert A, Prokesch A, Heininger C, Brandl I, et al.
Front Oncol
. 2022 Aug;
12:949071.
PMID: 36016616
Cytotoxic chemotherapy with or without a combination of humanized monoclonal antibodies is regarded as the gold standard of personalized medicine for the treatment of breast cancer patients. Significant medication-related side...